Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis
Abstract Background The aim of this study was to estimate the efficacy and safety of bevacizumab combined with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in advanced non‐small cell lung cancer (NSCLC) patients. Methods We searched randomized controlled trials (RCTs) on b...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wiley
2022-01-01
|
| Seria: | Thoracic Cancer |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1111/1759-7714.14214 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|